Preparation of a chemically stable quercetin formulation using nanosuspension technology

International Journal of Pharmaceutics

Volumn 404, Issue 1-2, 2011, Pages 231-237

  Gao, Lei ^a   Liu, Guiyang ^a   Wang, Xiaoqing ^a   Liu, Fei ^a   Xu, Yuefang ^a   Ma, Jing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Crystalline state; High pressure homogenization; Poorly soluble drugs; Precipitation; Quercetin; Stability

Indexed keywords

QUERCETIN;

AQUEOUS SOLUTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; EVAPORATION; NANOPHARMACEUTICS; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLIZATION; DRUG COMPOUNDING; DRUG STABILITY; FEASIBILITY STUDIES; KINETICS; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PHOTOLYSIS; POWDER DIFFRACTION; PRESSURE; QUERCETIN; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 78650679438     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.11.009     Document Type: Article

References (32)

1. A. Ain-Ai, and P.K. Gupta Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspension of a poorly soluble compound Int. J. Pharm. 351 2008 282 288
2. H.S.M. Ali, P. York, and N. Blagden Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors Int. J. Pharm. 375 2009 107 113
3. V.A. Bhattaram, U. Graefe, C. Kohlert, M. Veit, and H. Derendorf Pharmacokinetics and bioavailability of herbal medicinal products Phytomedicine 9 2002 1 33
4. B.H.L. Böhm, and R.H. Müller Lab-scale production unit design for nanosuspension of sparingly soluble cytotoxic drugs Pharm. Sci. Technol. Today 2 1999 336 339
5. G.S. Borghetti, I.S. Lula, R.D. Sinisterra, and V.L. Bassani Quercetin/β-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture AAPS Pharm. Sci. Technol. 10 2009 235 242
6. M.L. Calabr, S. Tommasini, P. Donato, D. Raneri, R. Stancanelli, P. Ficarra, R. Ficarra, C. Costa, S. Catania, C. Rustichelli, and G. Gamberini Effects of α- and β-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones J. Pharm. Biomed. Anal. 35 2004 365 377
7. M.M. Chan, D. Fong, K.J. Soprano, W.F. Holmes, and H. Heverling Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents J. Cell. Physiol. 194 2003 63 70
8. X. Chen, T.J. Young, M. Sarkari, R.O. Williams III, and K.P. Johnston Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution Int. J. Pharm. 242 2002 3 14
9. L. Gao, D. Zhang, M. Chen, T. Zheng, and S. Wang Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement Drug Dev. Ind. Pharm. 33 2007 1332 1339
10. L. Gao, D. Zhang, and M. Chen Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system J. Nanopart. Res. 10 2008 845 862
11. B. Hancock, and M. Parks What is the true solubility advantage for amorphous pharmaceuticals Pharm. Res. 17 2000 397 404
12. B.C. Hancock, G.T. Carlson, D.D. Ladipo, B.A. Langdon, and M.P. Mullarney Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance Int. J. Pharm. 241 2002 73 85
13. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, and K. Amighi Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine Int. J. Pharm. 299 2005 167 177
14. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, P. Boulanger, S.L. Lamer, and K. Amighi Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base Eur. J. Pharm. Biopharm. 64 2006 360 368
15. R.J. Hintz, and K.C. Johnson The effect of particle size distribution on dissolution rate and oral absorption Int. J. Pharm. 51 1989 9 17
16. P.C. Hollman, and M.B. Kata Dietary flavonoids: intake, health effects and bioavailability Food Chem. Toxicol. 37 1999 937 942
17. C.M. Keck, and R.H. Müller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization Eur. Pharm. Biopharm. 62 2006 3 16
18. K.A. Khaled, Y.M. El-Sayed, and B.M. Al-Hadiya Disposition of the avonoid quercetin in rats after single intravenous and oral doses Drug Dev. Ind. Pharm. 29 2003 397 403
19. X.S. Li, J.X. Wang, Z.G. Shen, P.Y. Zhang, J.F. Chen, and J. Yun Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method Int. J. Pharm. 342 2007 26 32
20. E.M. Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120
21. E. Lugli, R. Ferraresi, E. Roat, L. Troiano, M. Pinti, M. Nasi, E. Neme, L. Bertoncelli, L. Gibellini, P. Salomoni, E.L. Cooper, and A. Cossarizza Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells Leuk. Res. 33 2009 140 150
22. R.H. Müller, and C. Jacobs Buparvaquone mucoadhesive nanosuspension: preparation, optimization and long-term stability Int. J. Pharm. 237 2002 151 161
23. R.H. Müller, and C.M. Keck Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles J. Biotechnol. 113 2004 151 170
24. V.B. Patravale, A.A. Date, and R.M. Kulkarni Nanosuspension: a promsing drug delivery strategy J. Pharm. Pharmacol. 56 2004 827 840
25. R. Pignatello, N. Ricupero, C. Bucolo, F. Maugeri, A. Maltese, and G. Puglisi Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene AAPS Pharm. Sci. Technol. 7 2006 E27
26. X. Pu, J. Sun, Y. Wang, Y. Wang, X. Liu, P. Zhang, X. Tang, W. Pan, J. Han, and Z. He Development of a chemically stable 10-hydroxycamptothecin nanosuspension Int. J. Pharm. 379 2009 167 173
27. B.E. Rabinow Nanosuspension in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796
28. M. Sarkari, J. Brown, X. Chen, S. Swinnea, R.O. Williams III, and K.P. Johnston Enhanced drug dissolution using evaporative precipitation into aqueous solution Int. J. Pharm. 243 2002 17 31
29. S. Scalia, and M. Mezzena Incorporation of quercetin in lipid microparticles: effect on photo- and chemical-stability J. Pharm. Biomed. Anal. 49 2009 90 94
30. J.M. Schwitzera, G. Achleitner, H. Pomperb, and R.H. Müller Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology Eur. Pharm. Biopharm. 58 2004 615 619
31. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 2008 64 75
32. Y. Zheng, and A.H.L. Chow Production and characterization of a spray-dried hydroxypropyl-β-cyclodextrin/quercetin complex Drug Dev. Ind. Pharm. 35 2009 727 734